Grist, E., Dutey-Magni, P., Parry, M., Mendes, L., Sachdeva, A., Proudfoot, J. A., Hamid, A., Ismail, M., Oliveira, L. D. P., Dairo, O., Lall, S., Amos, C., Parmar, M., Davicioni, E., Lotan, T. L., Sweeney, C., Brown, L. C., Clarke, N. W., James, N. D., Attard, G. (2025). Transcriptome classification of PTEN inactivation to predict survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for metastatic prostate cancer (PC): An ancillary study of the STAMPEDE trials.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5003